Investor Relations
Investor Relations
Investor Relations
Business Overview
The company engages in business involving modern scientific technology, which has been transferred from the BGI group, for analysis and operations conducted by experts. This can be categorized into 2 types as follows:
Our company imports and distributes legally authorized medical devices and products related to our services. These include comprehensive genetic testing kits, Beta-thalassemia real-time PCR (qPCR) test kits, cell-free DNA (cfDNA) collection tubes, and Yumeta Probiotics Powder supplements.
IR Calendar
Read more
Investor Kits
View All
Form 56-1 One Report 2025
Financial Statement Quarter 1/2026
IR Contact
- Mr. Kittikun Rodrangnok
- Tel : 063-021-1580
- Email : bkgi_ir@bangkokgenomics.com
Email Alert
Subscribe to receive the latest announcements from the company thru e-mail.
